Clinical Trial Update: Acetylcholinesterase Inhibition and Orthostatic Hypotension in SCI [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigated acetylcholinesterase inhibition with pyridostigmine to treat orthostatic hypotension in individuals with spinal cord injury;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Orthostatic Hypotension
• Spinal Cord Injury

Drugs mentioned

• Pyridostigmine (pyridostigmine)

Snippet

Sponsor: James J. Peters Veterans Affairs Medical Center | Conditions: Hypotension, Postural | Phase 2 | Status: COMPLETED | Results posted: 2017-07-21